Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VORTIOXETINE HYDROBROMIDE Cause Secretion discharge? 9 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Secretion discharge have been filed in association with VORTIOXETINE HYDROBROMIDE (Trintellix). This represents 0.1% of all adverse event reports for VORTIOXETINE HYDROBROMIDE.

9
Reports of Secretion discharge with VORTIOXETINE HYDROBROMIDE
0.1%
of all VORTIOXETINE HYDROBROMIDE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Secretion discharge From VORTIOXETINE HYDROBROMIDE?

Of the 9 reports, 1 (11.1%) required hospitalization, and 4 (44.4%) were considered life-threatening.

Is Secretion discharge Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VORTIOXETINE HYDROBROMIDE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does VORTIOXETINE HYDROBROMIDE Cause?

Nausea (2,062) Anxiety (861) Vomiting (811) Suicidal ideation (742) Headache (738) Fatigue (697) Drug ineffective (693) Pruritus (653) Insomnia (636) Feeling abnormal (620)

What Other Drugs Cause Secretion discharge?

ADALIMUMAB (685) DUPILUMAB (626) ALBUTEROL (520) OMALIZUMAB (514) ETANERCEPT (487) METHOTREXATE (387) MEPOLIZUMAB (359) BUDESONIDE\FORMOTEROL (339) PREDNISONE (316) SECUKINUMAB (307)

Which VORTIOXETINE HYDROBROMIDE Alternatives Have Lower Secretion discharge Risk?

VORTIOXETINE HYDROBROMIDE vs VOSORITIDE VORTIOXETINE HYDROBROMIDE vs VOTRIENT VORTIOXETINE HYDROBROMIDE vs VOXELOTOR VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN VORTIOXETINE HYDROBROMIDE vs VX-950

Related Pages

VORTIOXETINE HYDROBROMIDE Full Profile All Secretion discharge Reports All Drugs Causing Secretion discharge VORTIOXETINE HYDROBROMIDE Demographics